Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men

Diabetes Care

Volumn 30, Issue 8, 2007, Pages 1972-1978

  Basu, Rita ^a   Dalla Man, Chiara ^b   Campioni, Marco ^b   Basu, Ananda ^a   Nair, K Sreekumaran ^a   Jensen, Michael D ^a   Khosla, Sundeep ^a   Klee, George ^a   Toffolo, Gianna ^b   Cobelli, Claudio ^b   Rizza, Robert A ^a  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; D TRANS; GLUCOSE; INSULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

AGED; AGING; ANDROGEN DEFICIENCY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HORMONE SUBSTITUTION; HUMAN; INSULIN CLEARANCE; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE;

ADMINISTRATION, CUTANEOUS; AGED; BLOOD GLUCOSE; BODY COMPOSITION; C-PEPTIDE; DOUBLE-BLIND METHOD; GLYCOLYSIS; HUMANS; INSULIN; LIVER; MALE; MIDDLE AGED; PLACEBOS; POSTPRANDIAL PERIOD; TESTOSTERONE;

EID: 34547660521     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0359     Document Type: Article

References (33)

1. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB: Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 87:589-598, 2002
2. Morley JE, Kaiser FE, Perry HM, III, Patrick P, Morley PMK, Stauber PM, Vellas B, Baumgartner RN, Garry PJ: Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulationg hormone in healthy older men. Metabolism 46:410-413, 1997
3. Basu R, Dalla Man C, Campioni M, Basu A, Klee G, Toffolo G, Cobelli C, Rizza RA: Effects of age and sex on postprandial glucose metabolism:differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 55:2001-2014, 2006
4. Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, Basu A, Vittone JL, Klee GG, Arora P, Jensen MD, Toffolo G, Cobelli C, Rizza RA: Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action and clearance. Diabetes 52:1738-1748, 2003
5. Vermeulen A, Kaufman JM, Giagulli VA: Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81:1821-1826, 1996
6. Holmang A, Bjorntorp P: The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand 146:505-510, 1992
7. Morimoto S, Fernandez-Mejia C, Romero-Navarro G, Morales-Peza N, Diaz-Sanchez V: Testosterone effect on insulin content, messenger ribonucleic acid levels, promoter activity, and secretion in the rat. Endocrinology 142:1442-1447, 2001
8. Pasquali R, Macor C, Vicennati V, Novo F, De Iasio R, Mesini P, Boschi S, Casimirri F, Vettor R: Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men. Metabolism 46:526-529, 1997
9. Tsai EC, Matsumoto AM, Fujimoto WY, Toyko EJ: Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 27:861-868, 2004
10. Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM: Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 87:4522-2527, 2002
11. Tibblin G, Adlerberth A, Lindstedt G, Bjorntorp P: The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 45:1605-1609, 1996
12. Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson W, Dobs A, Basaria S, Golden SH, Platz E: Androgens and diabetes in men: results from the Third National Health and Nutritional Examination Study (NHANES III). Diabetes Care 30:234-238, 2007
13. Marin P, Holmang S, Gustafsson C, Jonsson L, Kvist H, Elander A, Eldh J, Sjostrom L, Holm G, Bjorntorp P: Androgen treatment of abdominally obese men. Obesity Research 1:245-251, 1993
14. Marin P, Krotkiewski M, Bjorntorp P: Androgen treatment of middle-aged, obese men: Effects on metabolism, muscle and adipose tissues. Eur J Med 1:329-336, 1992
15. Byerley LO, Lee WNP, Swerdloff RS, Buena F, Nair KS, Buchanan TA, Goldberg RB, Steiner B, Bhasin S: Effect of modulating serum testosterone levels in the normal male range on protein, glucose and lipid metabolism in men: implications for testosterone replacement therapy. Endocrine J 1:253-262, 1993
16. Jedrzejuk D, Medras M, Milewicz A, Demissie M: Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism. The Aging Male 6:151-156, 2003
17. Godsland IF, Shennan NM, Wynn V: Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol). Clin Sci 71:665-673, 1986
18. Cohen JC, Hickman R: Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab 64:960-963, 1987
19. Wasserman DH, Ruzumna PA, Bracy DP, Lacy DB, Boothe HW, Williams PE, Abumrad NN: Impact of suprapharmacological androgenic steroid administration on basal and insulin-stimulated glucose and amino acid metabolism. Metabolism 43:1266-1274, 1994
20. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ, III, Smith GE, Khosla S, Jensen MD: DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647-1659, 2006
21. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen M, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza R: Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action or postprandial glucose turnover in elderly men or women. Diabetes 56:753-766, 2007
22. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C: Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 284:E55-E69, 2003
23. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C: Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab 287:E637-E643, 2004
24. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
25. Radziuk J, Norwich KH, Vranic M: Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol 234:E84-E93, 1978
26. Barret PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster D: SAAM II: simulation, analysis and modeling software for tracer and pharmacokinetic studies. Metabolism 47:484-492, 1998
27. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C: Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model. Am J Physiol Endocrinol Metab 289:E909-E914, 2005
28. Toffolo G, Campioni M, Rizza R, Cobelli C: A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. Am J Physiol Endocrinol Metab 290:E169-E176, 2006
29. Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid NF, Zheng W, Bhasin S: Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab 89:5245-5255, 2004
30. Ader M, Ni T-C, Bergman RN: Glucose effectiveness assessed under dynamic and steady state conditions. J Clin Invest 99:1187-1199, 1997
31. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA: Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 47:1735-1747
32. Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, Butler P, Rizza R: Assessment of beta cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose test. Am J Physiol Endocrinol Metab. 2007 Mar 6; [E-pub ahead of print]
33. Barrett-Connor E, Khaw K, Yen SSC: A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519-1524, 1986